Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma
Cited by 13
Related Papers
Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study
|Expert Review of Anticancer Therapy|2023|36
Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma
|Cell Death and Disease|2024|30
Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation system
|Nature Communications|2022|22
JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4
|Cancer Cell International|2021|20
Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
|Emerging infectious diseases|2018|15